The stock of Chemours Co (NYSE:CC) is a huge mover today! About 865,221 shares traded. Chemours Co (NYSE:CC) has risen 177.79% since August 19, 2016 and is uptrending. It has outperformed by 170.56% the S&P500.The move comes after 5 months positive chart setup for the $6.70B company. It was reported on Mar, 28 by Barchart.com. We have $39.45 PT which if reached, will make NYSE:CC worth $603.00M more.
Among 13 analysts covering TransUnion (NYSE:TRU), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. TransUnion had 22 analyst reports since July 27, 2015 according to SRatingsIntel. Barclays Capital initiated TransUnion (NYSE:TRU) on Monday, July 27 with “Equal Weight” rating. The rating was initiated by Goldman Sachs with “Neutral” on Tuesday, August 4. The stock of TransUnion (NYSE:TRU) has “Buy” rating given on Wednesday, June 8 by Stifel Nicolaus. The firm has “Outperform” rating given on Friday, April 8 by William Blair. Morgan Stanley upgraded the shares of TRU in report on Wednesday, January 18 to “Overweight” rating. The rating was initiated by JP Morgan on Tuesday, August 4 with “Overweight”. On Friday, March 18 the stock rating was maintained by Barclays Capital with “Equal-Weight”. The company was initiated on Tuesday, February 23 by Morgan Stanley. The company was initiated on Tuesday, August 4 by Deutsche Bank. On Tuesday, August 4 the stock rating was initiated by Evercore with “Buy”. See TransUnion (NYSE:TRU) latest ratings:
23/03/2017 Broker: Atlantic Securities Rating: Neutral Initiate
15/02/2017 Broker: Stifel Nicolaus Rating: Buy Old Target: $39 New Target: $43 Maintain
18/01/2017 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Overweight Upgrade
26/10/2016 Broker: Deutsche Bank Rating: Buy Old Target: $37 New Target: $38 Maintain
TransUnion is a risk and information solutions well-known provider to businesses and consumers. The company has market cap of $6.79 billion. The Firm provides consumer reports, risk scores, analytical services and decision capabilities to businesses. It has a 57.51 P/E ratio. The Firm operates through three divisions: U.S.
About 36,664 shares traded. TransUnion (NYSE:TRU) has risen 15.59% since August 19, 2016 and is uptrending. It has outperformed by 8.37% the S&P500.
Among 8 analysts covering Chemours (NYSE:CC), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. Chemours had 19 analyst reports since July 27, 2015 according to SRatingsIntel. Citigroup maintained Chemours Co (NYSE:CC) on Thursday, August 11 with “Neutral” rating. The firm earned “Underweight” rating on Friday, August 7 by JP Morgan. Argus Research upgraded the stock to “Buy” rating in Wednesday, August 10 report. Argus Research initiated Chemours Co (NYSE:CC) on Friday, September 18 with “Hold” rating. Jefferies maintained Chemours Co (NYSE:CC) rating on Thursday, September 1. Jefferies has “Hold” rating and $15 target. UBS downgraded the stock to “Sell” rating in Tuesday, August 18 report. The firm earned “Neutral” rating on Monday, December 12 by Goldman Sachs. The firm has “Hold” rating given on Tuesday, February 16 by Jefferies. The stock of Chemours Co (NYSE:CC) has “Buy” rating given on Monday, February 13 by Goldman Sachs. The stock of Chemours Co (NYSE:CC) earned “Buy” rating by Goldman Sachs on Monday, March 14.
The Chemours Company is a provider of performance chemicals. The company has market cap of $6.70 billion. The Firm operates through three divisions: Titanium Technologies, Fluoroproducts and Chemical Solutions. It has a 1186.56 P/E ratio. The Titanium Technologies segment is a producer of titanium dioxide .
